600201 生物股份
已收盘 01-08 15:00:00
资讯
新帖
简况
开源证券:给予生物股份买入评级
证券之星 · 56分钟前
开源证券:给予生物股份买入评级
1月6日生物股份发布公告,股东增持61.46万股
证券之星 · 01-06 17:32
1月6日生物股份发布公告,股东增持61.46万股
1月5日生物股份涨6.57%,国泰中证畜牧养殖ETF基金重仓该股
证券之星 · 01-05
1月5日生物股份涨6.57%,国泰中证畜牧养殖ETF基金重仓该股
生物股份涨6.57%,开源证券二个月前给出“买入”评级
证券之星 · 01-05
生物股份涨6.57%,开源证券二个月前给出“买入”评级
每周股票复盘:生物股份(600201)现240.04万元大宗交易
证券之星 · 01-02
每周股票复盘:生物股份(600201)现240.04万元大宗交易
生物股份(600201)股东内蒙古金宇生物控股有限公司质押840万股,占总股本0.76%
证券之星 · 2025-12-31
生物股份(600201)股东内蒙古金宇生物控股有限公司质押840万股,占总股本0.76%
12月30日生物股份现240.04万元大宗交易
证券之星 · 2025-12-30
12月30日生物股份现240.04万元大宗交易
每周股票复盘:生物股份(600201)大股东拟增持5000万至1亿元
证券之星 · 2025-12-28
每周股票复盘:生物股份(600201)大股东拟增持5000万至1亿元
12月24日生物股份跌7.69%,国泰中证畜牧养殖ETF基金重仓该股
证券之星 · 2025-12-24
12月24日生物股份跌7.69%,国泰中证畜牧养殖ETF基金重仓该股
生物股份(600201.SH):生物控股拟斥5000万元至1亿元增持公司股份
智通财经网 · 2025-12-23
生物股份(600201.SH):生物控股拟斥5000万元至1亿元增持公司股份
生物股份涨5.56%,开源证券一个月前给出“买入”评级
证券之星 · 2025-12-23
生物股份涨5.56%,开源证券一个月前给出“买入”评级
12月17日生物股份(600201)龙虎榜数据:机构净卖出9482.71万元,北向资金净卖出5491.7万元
证券之星 · 2025-12-17
12月17日生物股份(600201)龙虎榜数据:机构净卖出9482.71万元,北向资金净卖出5491.7万元
异动快报:生物股份(600201)12月17日10点20分触及跌停板
证券之星 · 2025-12-17
异动快报:生物股份(600201)12月17日10点20分触及跌停板
生物股份涨7.47%,开源证券一个月前给出“买入”评级
证券之星 · 2025-12-16
生物股份涨7.47%,开源证券一个月前给出“买入”评级
生物股份涨6.73%,开源证券一个月前给出“买入”评级
证券之星 · 2025-12-12
生物股份涨6.73%,开源证券一个月前给出“买入”评级
【新股IPO】上海君赛生物股份有限公司 - B向港交所主板提交上市申请
金吾财讯 · 2025-12-11
【新股IPO】上海君赛生物股份有限公司 - B向港交所主板提交上市申请
每周股票复盘:生物股份(600201)将召开2025年Q3业绩说明会
证券之星 · 2025-11-23
每周股票复盘:生物股份(600201)将召开2025年Q3业绩说明会
11月13日生物股份涨9.11%,国泰中证畜牧养殖ETF基金重仓该股
证券之星 · 2025-11-13
11月13日生物股份涨9.11%,国泰中证畜牧养殖ETF基金重仓该股
生物股份涨9.11%,中航证券二个月前给出“买入”评级
证券之星 · 2025-11-13
生物股份涨9.11%,中航证券二个月前给出“买入”评级
太平洋:给予生物股份买入评级
证券之星 · 2025-11-04
太平洋:给予生物股份买入评级
加载更多
公司概况
公司名称:
金宇生物技术股份有限公司
所属行业:
医药制造业
上市日期:
1999-01-15
主营业务:
金宇生物技术股份有限公司的主营业务是兽用生物制品的研发、生产与销售。公司的主要产品是猪用疫苗、反刍动物疫苗、禽用疫苗、宠物类疫苗。
发行价格:
6.83
{"stockData":{"symbol":"600201","market":"SH","secType":"STK","nameCN":"生物股份","latestPrice":16.61,"timestamp":1767855600000,"preClose":16.11,"halted":0,"volume":51737566,"delay":0,"changeRate":0.031,"floatShares":1112000000,"shares":1112000000,"eps":0.0907,"marketStatus":"已收盘","change":0.5,"latestTime":"01-08 15:00:00","open":16.2,"high":16.98,"low":16.06,"amount":853000000,"amplitude":0.0571,"askPrice":16.62,"askSize":447,"bidPrice":16.61,"bidSize":1184,"shortable":0,"etf":0,"ttmEps":0.0907,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767922200000},"marketStatusCode":5,"adr":0,"adjPreClose":16.11,"symbolType":"stock","openAndCloseTimeList":[[1767835800000,1767843000000],[1767848400000,1767855600000]],"highLimit":17.72,"lowLimit":14.5,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1111747826,"isCdr":false,"pbRate":3.38,"roa":"--","peRate":183.131202,"roe":"3.0%","epsLYR":0.1,"committee":0.171949,"marketValue":18466000000,"turnoverRate":0.0465,"status":0,"floatMarketCap":18466000000},"requestUrl":"/m/hq/s/600201","defaultTab":"news","newsList":[{"id":"2601368479","title":"开源证券:给予生物股份买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2601368479","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601368479?lang=zh_cn&edition=full","pubTime":"2026-01-08 18:32","pubTimestamp":1767868379,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司陈雪丽,王高展近期对生物股份进行研究并发布了研究报告《公司深度报告:非瘟亚单位疫苗全球首发在即,创新龙头成长动能强劲》,给予生物股份买入评级。最新盈利预测明细如下:该股最近90天内共有3家机构给出评级,买入评级3家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800032121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201","161027"],"gpt_icon":0},{"id":"2601982598","title":"1月6日生物股份发布公告,股东增持61.46万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601982598","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601982598?lang=zh_cn&edition=full","pubTime":"2026-01-06 17:32","pubTimestamp":1767691951,"startTime":"0","endTime":"0","summary":"证券之星消息,1月6日生物股份发布公告《生物股份:生物股份关于大股东首次增持公司股份暨增持计划实施进展的公告》,其股东内蒙古金宇生物控股有限公司于2026年1月6日合计增持61.46万股,占公司目前总股本的0.0553%,变动期间该股股价上涨0.25%,截止1月6日收盘报16.1元。股东增减持详情见下表:根据生物股份2025年三季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600029153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0188","BK0239","BK0077","BK0012","BK0185","600201","BK0028","BK0196"],"gpt_icon":0},{"id":"2601100515","title":"1月5日生物股份涨6.57%,国泰中证畜牧养殖ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601100515","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601100515?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:31","pubTimestamp":1767598294,"startTime":"0","endTime":"0","summary":"证券之星消息,1月5日生物股份涨6.57%,收盘报16.06元,换手率4.98%,成交量55.33万手,成交额8.85亿元。重仓生物股份的公募基金请见下表:该股最近90天内共有3家机构给出评级,买入评级3家。根据2025基金Q3季报公募基金重仓股数据,重仓该股的公募基金共8家,其中持有数量最多的公募基金为国泰基金的国泰中证畜牧养殖ETF。国泰中证畜牧养殖ETF目前规模为60.97亿元,最新净值0.6319,较上一交易日下跌0.75%,近一年上涨11.41%。该公募基金现任基金经理为梁杏。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015332.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201","BK0028","BK0188","516670","BK0185","BK0046","BK0239","BK0012","BK0196","BK0077"],"gpt_icon":0},{"id":"2601059290","title":"生物股份涨6.57%,开源证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2601059290","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601059290?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:31","pubTimestamp":1767598286,"startTime":"0","endTime":"0","summary":"今日生物股份涨6.57%,收盘报16.06元。2025年10月28日,开源证券研究员陈雪丽,王高展发布了对生物股份的研报《公司信息更新报告:业绩修复向上,非瘟疫苗临床实验有序推进》,该研报对生物股份给出“买入”评级。公司业绩修复向上,非瘟疫苗研发加速,新品多点开花持续成长,维持“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为16.03%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015328.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201","161027"],"gpt_icon":0},{"id":"2600036184","title":"每周股票复盘:生物股份(600201)现240.04万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2600036184","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600036184?lang=zh_cn&edition=full","pubTime":"2026-01-02 03:04","pubTimestamp":1767294252,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,生物股份报收于15.34元,较上周的14.97元上涨2.47%。本周,生物股份12月23日盘中最高价报16.9元。本周关注点交易信息汇总:生物股份12月30日发生240.04万元大宗交易。本次质押后,生物控股累计质押公司股份数量为27,000,000股,占其持股总数的22.08%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200000777.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0046","600201","BK0185","BK0196","BK0188","BK0028","BK0239","BK0012"],"gpt_icon":0},{"id":"2595877325","title":"生物股份(600201)股东内蒙古金宇生物控股有限公司质押840万股,占总股本0.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595877325","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595877325?lang=zh_cn&edition=full","pubTime":"2025-12-31 18:42","pubTimestamp":1767177731,"startTime":"0","endTime":"0","summary":"证券之星消息,生物股份12月31日公开信息显示,股东内蒙古金宇生物控股有限公司向中国民生银行股份有限公司呼和浩特分行合计质押840.0万股,占总股本0.76%。质押详情见下表:截止本公告日,股东内蒙古金宇生物控股有限公司已累计质押股份2700.0万股,占其持股总数的22.08%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100035204.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0046","BK0012","BK0185","BK0188","BK0077","BK0028","BK0239","600201"],"gpt_icon":0},{"id":"2595934267","title":"12月30日生物股份现240.04万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2595934267","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595934267?lang=zh_cn&edition=full","pubTime":"2025-12-30 17:42","pubTimestamp":1767087774,"startTime":"0","endTime":"0","summary":"证券之星消息,12月30日生物股份发生大宗交易,交易数据如下:大宗交易成交价格16.23元,相对当日收盘价溢价8.2%,成交14.79万股,成交金额240.04万元,买方营业部为国联民生证券股份有限公司浙江分公司,卖方营业部为财通证券股份有限公司杭州金城路证券营业部。近三个月该股共发生1笔大宗交易,合计成交1479.0手,溢价成交1笔。截至2025年12月30日收盘,生物股份报收于15.0元,下跌2.53%,换手率3.55%,成交量39.43万手,成交额5.96亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000029871.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0185","BK0046","BK0239","BK0012","600201","BK0028","BK0077","BK0188"],"gpt_icon":0},{"id":"2594241691","title":"每周股票复盘:生物股份(600201)大股东拟增持5000万至1亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594241691","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594241691?lang=zh_cn&edition=full","pubTime":"2025-12-28 01:29","pubTimestamp":1766856548,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,生物股份报收于15.34元,较上周的14.97元上涨2.47%。本周,生物股份12月23日盘中最高价报16.9元。生物股份当前最新总市值170.54亿元,在动物保健板块市值排名1/11,在两市A股市值排名1151/5178。生物控股承诺在增持期间及完成后法定期限内不减持所持股份。生物股份关于大股东取得增持专项贷款承诺函的公告大股东内蒙古金宇生物控股有限公司计划在未来12个月内以集中竞价方式增持公司股份,金额不低于5000万元且不超过10000万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800000165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0046","BK0077","600201","BK0188","BK0239","BK0028","BK0185","BK0196"],"gpt_icon":0},{"id":"2593422295","title":"12月24日生物股份跌7.69%,国泰中证畜牧养殖ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2593422295","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593422295?lang=zh_cn&edition=full","pubTime":"2025-12-24 15:32","pubTimestamp":1766561537,"startTime":"0","endTime":"0","summary":"证券之星消息,12月24日生物股份跌7.69%,收盘报15.6元,换手率10.29%,成交量114.35万手,成交额17.99亿元。重仓生物股份的公募基金请见下表:该股最近90天内共有3家机构给出评级,买入评级3家。根据2025基金Q3季报公募基金重仓股数据,重仓该股的公募基金共8家,其中持有数量最多的公募基金为国泰基金的国泰中证畜牧养殖ETF。国泰中证畜牧养殖ETF目前规模为60.97亿元,最新净值0.6374,较上一交易日下跌0.52%,近一年上涨11.06%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400019491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201","BK0185","BK0188","BK0196","BK0028","BK0077","516670","BK0012","BK0046","BK0239"],"gpt_icon":0},{"id":"2593124496","title":"生物股份(600201.SH):生物控股拟斥5000万元至1亿元增持公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2593124496","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593124496?lang=zh_cn&edition=full","pubTime":"2025-12-23 17:57","pubTimestamp":1766483875,"startTime":"0","endTime":"0","summary":"智通财经APP讯,生物股份(600201.SH)发布公告,基于对公司未来持续稳定发展的信心和长期投资价值的认可,增强投资者信心,公司大股东内蒙古金宇生物控股有限公司(简称“生物控股”)计划自公告披露之日起12个月内,通过上海证券交易所系统以集中竞价方式增持公司股份,增持总金额不低于人民币5000万元,不超过人民币1亿元。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384991.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0188","BK0046","BK0028","BK0196","BK0185","600201","BK0239","BK0077","BK0012"],"gpt_icon":0},{"id":"2593467875","title":"生物股份涨5.56%,开源证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2593467875","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593467875?lang=zh_cn&edition=full","pubTime":"2025-12-23 15:32","pubTimestamp":1766475123,"startTime":"0","endTime":"0","summary":"今日生物股份涨5.56%,收盘报16.9元。2025年10月28日,开源证券研究员陈雪丽,王高展发布了对生物股份的研报《公司信息更新报告:业绩修复向上,非瘟疫苗临床实验有序推进》,该研报对生物股份给出“买入”评级。公司业绩修复向上,非瘟疫苗研发加速,新品多点开花持续成长,维持“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为中金公司的樊俊豪。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300019309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201","161027"],"gpt_icon":0},{"id":"2592699517","title":"12月17日生物股份(600201)龙虎榜数据:机构净卖出9482.71万元,北向资金净卖出5491.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592699517","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592699517?lang=zh_cn&edition=full","pubTime":"2025-12-17 17:48","pubTimestamp":1765964899,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2025年12月17日公布的交易公开信息显示,生物股份因有价格涨跌幅限制的日收盘价格跌幅偏离值达到7%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年12月17日收盘,生物股份报收于15.28元,下跌10.01%,跌停,换手率8.44%,成交量93.79万手,成交额14.85亿元。从龙虎榜公布的当日买卖数据来看,机构合计净卖出9482.71万元,北向资金合计净卖出5491.7万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700028189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0046","BK0028","600201","BK0012","BK0239","BK0185","BK0188","BK0077"],"gpt_icon":0},{"id":"2592578199","title":"异动快报:生物股份(600201)12月17日10点20分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2592578199","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592578199?lang=zh_cn&edition=full","pubTime":"2025-12-17 10:25","pubTimestamp":1765938328,"startTime":"0","endTime":"0","summary":"证券之星12月17日盘中消息,10点20分生物股份(600201)触及跌停板。其所属行业动物保健目前下跌。领涨股为中牧股份。该股为宠物经济,内蒙古概念,禽流感概念热股。12月16日的资金流向数据方面,主力资金净流出621.92万元,占总成交额0.57%,游资资金净流出595.83万元,占总成交额0.55%,散户资金净流入1217.75万元,占总成交额1.12%。近5日资金流向一览见下表:生物股份主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700009610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0188","600201","BK0196","BK0185","BK0028","BK0046","BK0077","BK0239"],"gpt_icon":0},{"id":"2591609433","title":"生物股份涨7.47%,开源证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2591609433","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591609433?lang=zh_cn&edition=full","pubTime":"2025-12-16 15:31","pubTimestamp":1765870311,"startTime":"0","endTime":"0","summary":"今日生物股份涨7.47%,收盘报16.98元。2025年10月28日,开源证券研究员陈雪丽,王高展发布了对生物股份的研报《公司信息更新报告:业绩修复向上,非瘟疫苗临床实验有序推进》,该研报对生物股份给出“买入”评级。公司业绩修复向上,非瘟疫苗研发加速,新品多点开花持续成长,维持“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为17.81%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600019986.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201","161027"],"gpt_icon":0},{"id":"2590575995","title":"生物股份涨6.73%,开源证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2590575995","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590575995?lang=zh_cn&edition=full","pubTime":"2025-12-12 15:31","pubTimestamp":1765524706,"startTime":"0","endTime":"0","summary":"今日生物股份涨6.73%,收盘报15.7元。2025年10月28日,开源证券研究员陈雪丽,王高展发布了对生物股份的研报《公司信息更新报告:业绩修复向上,非瘟疫苗临床实验有序推进》,该研报对生物股份给出“买入”评级。公司业绩修复向上,非瘟疫苗研发加速,新品多点开花持续成长,维持“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为中金公司的樊俊豪。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200018506.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201","161027"],"gpt_icon":0},{"id":"2590053911","title":"【新股IPO】上海君赛生物股份有限公司 - B向港交所主板提交上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2590053911","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590053911?lang=zh_cn&edition=full","pubTime":"2025-12-11 00:24","pubTimestamp":1765383850,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据港交所12月10日披露,上海君赛生物股份有限公司 - B向港交所主板提交上市申请,中信证券为独家保荐人。公司是生物科技企业,根据弗若斯特沙利文的资料,公司的核心产品GC101是全球首款无需高强度清淋化疗、无需IL-2给药的肿瘤浸润淋巴细胞(TIL)疗法,有望成为中国首个获批上市的TIL疗法。财务方面,截至2023年、2024年12月31日止年度及2025年截至6月30日止六个月,公司研发成本分别约为5762万元(人民币,下同)、9099万元、5280.1万元;对应同期,年/期内母公司拥有人应占亏损分别为9439.1万元、1.64亿元、9758万元。","market":"us","thumbnail":"https://static.szfiu.com/news/20250107/NDRlODdhNTE5YzIwYjYxODZjOWYzMjY3ODIxMDI2ODM=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NDRlODdhNTE5YzIwYjYxODZjOWYzMjY3ODIxMDI2ODM=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971317","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK0012","BK0196","HEXmain","BK0185","600201","BK0188","BK0046","BK0077","BK0239"],"gpt_icon":0},{"id":"2585103541","title":"每周股票复盘:生物股份(600201)将召开2025年Q3业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2585103541","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585103541?lang=zh_cn&edition=full","pubTime":"2025-11-23 02:25","pubTimestamp":1763835913,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘,生物股份报收于11.76元,较上周的11.93元下跌1.42%。本周,生物股份11月20日盘中最高价报12.45元,股价触及近一年最高点。公司公告汇总生物股份关于召开2025年第三季度业绩说明会的公告金宇生物技术股份有限公司将于2025年11月26日15:00-17:00通过上证路演中心举行2025年第三季度业绩说明会,介绍公司2025年第三季度经营成果及财务状况,并与投资者进行互动交流。投资者可于11月19日至11月25日16:00前通过上证路演中心或公司邮箱提交问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000516.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0239","BK0188","BK0046","BK0196","600201","BK0028","BK0077","BK0185"],"gpt_icon":0},{"id":"2583554267","title":"11月13日生物股份涨9.11%,国泰中证畜牧养殖ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2583554267","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583554267?lang=zh_cn&edition=full","pubTime":"2025-11-13 16:25","pubTimestamp":1763022329,"startTime":"0","endTime":"0","summary":"证券之星消息,11月13日生物股份涨9.11%创60日新高,收盘报11.74元,换手率10.37%,成交量115.3万手,成交额13.0亿元。根据2025基金Q3季报公募基金重仓股数据,重仓该股的公募基金共8家,其中持有数量最多的公募基金为国泰基金的国泰中证畜牧养殖ETF。国泰中证畜牧养殖ETF目前规模为60.97亿元,最新净值0.6589,较上一交易日下跌0.63%,近一年上涨8.69%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300027506.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0185","BK0028","BK0046","516670","BK0077","BK0196","BK0012","BK0188","600201"],"gpt_icon":0},{"id":"2583554269","title":"生物股份涨9.11%,中航证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2583554269","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583554269?lang=zh_cn&edition=full","pubTime":"2025-11-13 16:25","pubTimestamp":1763022321,"startTime":"0","endTime":"0","summary":"今日生物股份涨9.11%,收盘报11.74元。2025年8月25日,中航证券研究员彭海兰,陈翼发布了对生物股份的研报《非瘟疫苗领先,创新驱动成长》,该研报对生物股份给出“买入”评级。研报中预计公司2025-2027年归母净利润分别为1.61亿元、2.81亿元、4.06亿元,EPS分别为0.15元、0.25元、0.37元,对应25、26、27年PE分别为63.13 、36.30、25.07倍,维持“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为39.39%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300027502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201","161027"],"gpt_icon":0},{"id":"2580847177","title":"太平洋:给予生物股份买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2580847177","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580847177?lang=zh_cn&edition=full","pubTime":"2025-11-04 18:39","pubTimestamp":1762252746,"startTime":"0","endTime":"0","summary":"太平洋证券股份有限公司程晓东,李忠华近期对生物股份进行研究并发布了研究报告《2025年三季报点评:核心单品持续放量,新型疫苗稳步推进》,给予生物股份买入评级。最新盈利预测明细如下:该股最近90天内共有5家机构给出评级,买入评级4家,增持评级1家;过去90天内机构目标均价为10.0。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400032502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601099","600201"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1767871679265,"stockEarnings":[{"period":"1week","weight":0.069},{"period":"1month","weight":0.1195},{"period":"3month","weight":0.6557},{"period":"6month","weight":1.0341},{"period":"1year","weight":1.4573},{"period":"ytd","weight":0.069}],"compareEarnings":[{"period":"1week","weight":0.0295},{"period":"1month","weight":0.0412},{"period":"3month","weight":0.0386},{"period":"6month","weight":0.164},{"period":"1year","weight":0.2651},{"period":"ytd","weight":0.0295}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"金宇生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"49033人(较上一季度减少10.70%)","perCapita":"22673股","listingDate":"1999-01-15","address":"内蒙古自治区呼和浩特市土默特左旗经济技术开发区沙尔沁工业园区金宇大街1号","registeredCapital":"111174万元","survey":" 金宇生物技术股份有限公司的主营业务是兽用生物制品的研发、生产与销售。公司的主要产品是猪用疫苗、反刍动物疫苗、禽用疫苗、宠物类疫苗。","listedPrice":6.83},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物股份(600201)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物股份(600201)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物股份,600201,生物股份股票,生物股份股票老虎,生物股份股票老虎国际,生物股份行情,生物股份股票行情,生物股份股价,生物股份股市,生物股份股票价格,生物股份股票交易,生物股份股票购买,生物股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物股份(600201)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物股份(600201)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}